Harvard Bioscience, Inc. (HBIO)
0.5538
-0.01
(-1.11%)
USD |
NASDAQ |
Feb 13, 14:18
Harvard Bioscience Free Cash Flow : 6.133M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Agenus, Inc. | -89.31M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.83M |
| Cash from Investing (Quarterly) | -0.348M |
| Cash from Financing (Quarterly) | -1.024M |
| Free Cash Flow Per Share (Quarterly) | 0.0108 |
| Free Cash Flow to Equity (Quarterly) | 1.011M |
| Free Cash Flow to Firm (Quarterly) | 1.531M |
| Free Cash Flow Yield | 24.97% |